GT BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $50.6M | $54.0K | $47.0K |
| FY2016 | $18.9M | $25.0K | $19.0K |
| FY2017 | $2.7M | $254.4M | $576.0K |
| FY2018 | $14.0M | $25.4M | $60.0K |
| FY2019 | $19.7M | $396.0K | $28.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $50.6M | $54.0K | $47.0K |
| FY2016 | $18.9M | $25.0K | $19.0K |
| FY2017 | $2.7M | $254.4M | $576.0K |
| FY2018 | $14.0M | $25.4M | $60.0K |
| FY2019 | $19.7M | $396.0K | $28.0K |